Ad
OKYO Quote Trading Chart OKYO Pharma Limited
home / stock / okyo / okyo quote
Quote | OKYO Pharma Limited (NASDAQ:OKYO)
| Last: | $1.37 |
|---|---|
| Change Percent: | 1.34% |
| Open: | $1.47 |
| Close: | $1.37 |
| High: | $1.4944 |
| Low: | $1.36 |
| Volume: | 54,251 |
| Last Trade Date Time: | 03/18/2025 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
OKYO Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $1.37 | $1.47 | $1.37 | $1.4944 | $1.36 | 54,251 | 03-18-2025 |
| $1.49 | $1.5 | $1.49 | $1.5 | $1.485 | 87,026 | 03-17-2025 |
| $1.5088 | $1.5 | $1.5088 | $1.54 | $1.49 | 30,022 | 03-14-2025 |
| $1.49 | $1.5 | $1.49 | $1.5799 | $1.39 | 71,810 | 03-13-2025 |
| $1.51 | $1.45 | $1.51 | $1.53 | $1.33 | 1,262,115 | 03-12-2025 |
| $1.39 | $1.41 | $1.39 | $1.41 | $1.31 | 53,642 | 03-11-2025 |
| $1.3599 | $1.43 | $1.3599 | $1.4367 | $1.31 | 70,056 | 03-10-2025 |
| $1.43 | $1.4 | $1.43 | $1.45 | $1.387 | 181,167 | 03-07-2025 |
| $1.37 | $1.38 | $1.37 | $1.38 | $1.32 | 54,905 | 03-06-2025 |
| $1.39 | $1.22 | $1.39 | $1.41 | $1.17 | 154,499 | 03-05-2025 |
| $1.26 | $1.25 | $1.26 | $1.27 | $1.14 | 92,697 | 03-04-2025 |
| $1.26 | $1.26 | $1.26 | $1.27 | $1.2201 | 99,072 | 03-03-2025 |
| $1.2599 | $1.14 | $1.2599 | $1.27 | $1.14 | 646,588 | 02-28-2025 |
| $1.15 | $1.2 | $1.15 | $1.21 | $1.1235 | 125,707 | 02-27-2025 |
| $1.18 | $1.15 | $1.18 | $1.2 | $1.09 | 263,169 | 02-26-2025 |
| $1.13 | $1.1 | $1.13 | $1.15 | $1.08 | 331,490 | 02-25-2025 |
| $1.08 | $1.14 | $1.08 | $1.15 | $1.08 | 36,825 | 02-24-2025 |
| $1.115 | $1.11 | $1.115 | $1.15 | $1.0988 | 109,161 | 02-21-2025 |
| $1.09 | $1.09 | $1.09 | $1.11 | $1.07 | 84,567 | 02-20-2025 |
| $1.0754 | $1.1098 | $1.0754 | $1.11 | $1.07 | 36,833 | 02-19-2025 |
News, Short Squeeze, Breakout and More Instantly...
OKYO Pharma Limited Company Name:
OKYO Stock Symbol:
NASDAQ Market:
1.34% G/L:
$1.37 Last:
54,251 Volume:
$1.47 Open:
$1.37 Close:
OKYO Pharma Limited Website:
Ad
-
LONDON and NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO ), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, and for inflammator...
-
LONDON and NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammator...
-
LONDON and NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammator...